Atlas Trials

A Pharmacokinetic Study of VCT220 in Particicants With Hepatic Injury and Normal Hepatic Function

Clinical trial NCT06938529 · COMPLETED

Trial details

NCT number
NCT06938529
Sponsor
Vincentage Pharma Co., Ltd
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Obesity, Overweight
Start date
2025-04-18
Primary completion
2025-07-15
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.